Free Trial

Cerus (CERS) Competitors

Cerus logo
$1.58 0.00 (0.00%)
(As of 05:45 PM ET)

CERS vs. STAA, OSUR, ANIK, UTMD, WST, COO, ALGN, MMSI, HAE, and XRAY

Should you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry.

Cerus vs.

STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, community ranking, valuation, earnings, dividends, analyst recommendations and risk.

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 3.4% of Cerus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

STAAR Surgical presently has a consensus target price of $42.83, indicating a potential upside of 77.22%. Cerus has a consensus target price of $3.63, indicating a potential upside of 129.43%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cerus
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

STAAR Surgical has a net margin of 6.38% compared to Cerus' net margin of -11.19%. STAAR Surgical's return on equity of 6.77% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical6.38% 6.77% 5.39%
Cerus -11.19%-37.90%-10.35%

Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 55.38% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
288
55.38%
Underperform Votes
232
44.62%
CerusOutperform Votes
569
72.30%
Underperform Votes
218
27.70%

STAAR Surgical has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$341.22M3.49$21.35M$0.4454.93
Cerus$176.23M1.67-$37.49M-$0.11-14.36

In the previous week, STAAR Surgical had 3 more articles in the media than Cerus. MarketBeat recorded 7 mentions for STAAR Surgical and 4 mentions for Cerus. STAAR Surgical's average media sentiment score of 1.30 beat Cerus' score of 0.60 indicating that STAAR Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500.

Summary

STAAR Surgical beats Cerus on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CERS vs. The Competition

MetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$293.43M$4.33B$5.20B$9.16B
Dividend YieldN/A44.59%5.12%4.27%
P/E Ratio-14.3625.2387.7017.16
Price / Sales1.6745.661,139.33122.80
Price / CashN/A43.4043.2337.85
Price / Book5.457.074.804.78
Net Income-$37.49M$13.64M$120.46M$225.43M
7 Day Performance-12.22%-1.68%-0.84%-0.68%
1 Month Performance-11.73%-1.41%14.85%1.06%
1 Year Performance-29.78%38.69%29.53%15.74%

Cerus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CERS
Cerus
2.9764 of 5 stars
$1.58
flat
$3.63
+129.4%
-29.8%$293.43M$176.23M-14.36625
STAA
STAAR Surgical
4.8519 of 5 stars
$24.37
-2.0%
$42.83
+75.8%
-21.5%$1.20B$322.42M56.501,115
OSUR
OraSure Technologies
4.3637 of 5 stars
$4.01
+2.6%
$5.50
+37.2%
-56.1%$299.12M$224.26M27.60638
ANIK
Anika Therapeutics
3.6851 of 5 stars
$17.02
-0.8%
$24.50
+43.9%
-30.0%$249.28M$164.17M-2.58357News Coverage
UTMD
Utah Medical Products
2.0119 of 5 stars
$63.05
+0.7%
N/A-28.4%$213.74M$50.22M14.73180
WST
West Pharmaceutical Services
4.9637 of 5 stars
$331.34
+0.4%
$437.75
+32.1%
-6.6%$24.00B$2.95B48.9710,600
COO
Cooper Companies
3.3696 of 5 stars
$95.03
+0.2%
$117.00
+23.1%
+0.1%$18.97B$3.90B48.6415,000
ALGN
Align Technology
4.9118 of 5 stars
$231.68
-1.6%
$271.20
+17.1%
-22.4%$17.30B$3.96B40.1721,610
MMSI
Merit Medical Systems
4.4095 of 5 stars
$102.60
-0.2%
$105.09
+2.4%
+29.9%$5.98B$1.33B50.476,950Analyst Forecast
HAE
Haemonetics
4.5947 of 5 stars
$82.16
+1.2%
$108.78
+32.4%
-14.3%$4.13B$1.36B33.693,657
XRAY
DENTSPLY SIRONA
4.8852 of 5 stars
$19.99
+1.4%
$28.40
+42.1%
-46.9%$3.97B$3.90B-9.5315,000

Related Companies and Tools


This page (NASDAQ:CERS) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners